New Data Presented at the American Psychiatric Association Annual Meeting May Shape the Standard of Care for Bipolar Disorder

New Data Presented at the American Psychiatric Association Annual
Meeting May Shape the Standard of Care for Bipolar Disorder 


NEW YORK, May 5  /PRNewswire/ -- "These preliminary findings should shape the
standard of care for bipolar disorder going forward," says Joseph Calabrese,
MD, co-Director of the National Institute of Mental Health Bipolar Research
Center at University Hospitals of Cleveland and Case Western Reserve
University.

The condition (bipolar I and II) affects approximately 8 million Americans, who
have relied on a combination of drugs to manage their symptoms.

For the first time, researchers have demonstrated in separate short-term trials
that a single drug therapy may be effective in treating both the manic and
depressive phases of bipolar disorder.

Dr. Calabrese will present these data at the annual meeting of the American
Psychiatric Association in New York City on Wednesday, May 5 beginning at 3pm.

ADDITIONAL RESOURCES:  Video version and more available at
http://www.prnewswire.com/broadcast/12208/consumer.shtml

SOUNDBITES:

Joseph Calabrese, MD, Co-Director of the National Institute of Mental Health
Bipolar Research Center at University Hospitals of Cleveland and Case Western
Reserve University.

VIDEO PROVIDED BY:  AstraZeneca 

http://www.prnewswire.com/broadcast/12208/consumer.shtmlDATASOURCE: AstraZeneca



CONTACT:  MultiVu Media Relations, 1-800-653-5313, ext. 3, for

AstraZeneca



Web site:  http://www.multivu.com/ 

Copyright